These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 26917483

  • 1. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
    Niu YJ, Shi HR, Xie Y.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S, Chen X, Lu X, Yu Y, Feng Y.
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [Abstract] [Full Text] [Related]

  • 3. [Influence of long-term treatment with MPA on the biological character of endometrial carcinoma Ishikawa cell].
    Zhao SJ, Chen XJ, Feng YJ.
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2007 Apr; 40(2):103-12. PubMed ID: 17580663
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y, Tong J, Ai Z, Wang J, Teng Y.
    J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
    [Abstract] [Full Text] [Related]

  • 5. [Study of mechanism of medroxyprogesterone 17-acetate on the cancer stem cell-like properties of human endometrial cancer].
    Liu BJ, Li XP, Zhao LJ, Wang JL, Wei LH.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):772-7. PubMed ID: 24406136
    [Abstract] [Full Text] [Related]

  • 6. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
    Wang J, Shi H, Xie Y, Peng Z.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
    [Abstract] [Full Text] [Related]

  • 7. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
    Guy MS, Qamar L, Behbakht K, Post MD, Sheeder J, Sartorius CA, Spillman MA.
    Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y, Anzai Y, Murphy LC, Ballejo G, Holinka CF, Gurpide E, Murphy LJ.
    Cancer Res; 1991 Oct 15; 51(20):5476-81. PubMed ID: 1833051
    [Abstract] [Full Text] [Related]

  • 9. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y, Wang YL, Yu L, Hu Q, Ji L, Zhang Y, Liao QP.
    J Steroid Biochem Mol Biol; 2011 Sep 15; 126(3-5):113-20. PubMed ID: 21168492
    [Abstract] [Full Text] [Related]

  • 10. Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate.
    Zhao S, Li G, Yang L, Li L, Li H.
    Oncol Lett; 2013 Jan 15; 5(1):139-144. PubMed ID: 23255909
    [Abstract] [Full Text] [Related]

  • 11. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.
    Zhang Z, Dong L, Sui L, Yang Y, Liu X, Yu Y, Zhu Y, Feng Y.
    Int J Gynecol Cancer; 2011 Feb 15; 21(2):213-21. PubMed ID: 21270604
    [Abstract] [Full Text] [Related]

  • 12. Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer.
    Gu W, Mitsuhashi A, Kobayashi T, Shozu M.
    BMC Cancer; 2022 Jul 11; 22(1):753. PubMed ID: 35820883
    [Abstract] [Full Text] [Related]

  • 13. [Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells].
    Zhang J, Zhang B, Yin Z, Chen F, Liu T, Xu H, Liu Y, Zhou X.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec 11; 49(12):932-7. PubMed ID: 25608995
    [Abstract] [Full Text] [Related]

  • 14. Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells.
    Cao W, Gao W, Zheng P, Sun X, Wang L.
    BMC Med Genomics; 2019 Nov 12; 12(1):163. PubMed ID: 31718641
    [Abstract] [Full Text] [Related]

  • 15. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.
    Wang Y, Zhang L, Che X, Li W, Liu Z, Jiang J.
    Arch Gynecol Obstet; 2018 Nov 12; 298(5):961-969. PubMed ID: 30206735
    [Abstract] [Full Text] [Related]

  • 16. Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells.
    Alkhalaf M, Murphy LJ, Murphy LC.
    Mol Endocrinol; 1993 Dec 12; 7(12):1634-41. PubMed ID: 8145769
    [Abstract] [Full Text] [Related]

  • 17. 5-aza-2'-deoxycytidine improves the sensitivity of endometrial cancer cells to progesterone therapy.
    Hu Q, Yu L, Chen R, Wang YL, Ji L, Zhang Y, Xie Y, Liao QP.
    Int J Gynecol Cancer; 2012 Jul 12; 22(6):951-9. PubMed ID: 22683940
    [Abstract] [Full Text] [Related]

  • 18. Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.
    Gu C, Zhang Z, Yu Y, Liu Y, Zhao F, Yin L, Feng Y, Chen X.
    Cancer Sci; 2011 Mar 12; 102(3):557-64. PubMed ID: 21205080
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effect of metformin and medroxyprogesterone 17‑acetate on the development of endometrial cancer.
    Mu N, Dong M, Li L, Xia M, Qv L, Wang Y, Dong C, Chen Y, Zuo Y, Hou J, Xue F.
    Oncol Rep; 2018 Apr 12; 39(4):2015-2021. PubMed ID: 29393479
    [Abstract] [Full Text] [Related]

  • 20. MET Inhibits the Proliferation of EC Cells by Increasing MPA Sensitivity.
    Sun F, Zhou J, Hao Y, Kuang L, Zhang B.
    Altern Ther Health Med; 2023 Jul 12; 29(5):334-341. PubMed ID: 37171945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.